MeSH term
Frequency | Condition_Probility | Animals | 6 | 0.0 |
Humans | 26 | 0.0 |
Mice | 5 | 0.0 |
Rats | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Vault Ribonucleoprotein Particles/*metabolism | 2 | 28.0 |
Amino Acid Sequence | 3 | 0.0 |
Calcium/metabolism | 2 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Base Sequence | 2 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Drug Resistance, Multiple | 3 | 1.0 |
Drug Resistance, Neoplasm | 2 | 0.0 |
Female | 11 | 0.0 |
Male | 9 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Transfection | 2 | 0.0 |
Vault Ribonucleoprotein Particles/*biosynthesis/genetics/metabolism | 2 | 100.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Vault Ribonucleoprotein Particles/*biosynthesis | 2 | 50.0 |
Immunohistochemistry | 3 | 0.0 |
Middle Aged | 7 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Adult | 9 | 0.0 |
Electrocardiography, Ambulatory | 2 | 6.0 |
English Abstract | 4 | 0.0 |
Heart Rate | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Aged | 3 | 0.0 |
Comparative Study | 3 | 0.0 |
Echocardiography, Doppler | 2 | 5.0 |
Phenotype | 2 | 0.0 |
Echocardiography | 3 | 1.0 |
Protein Binding | 2 | 0.0 |
Echocardiography/*methods | 2 | 28.0 |
Follow-Up Studies | 2 | 0.0 |
Child | 2 | 0.0 |
